HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

MPLT

MapLight Therapeutics Inc

Last Close
37.87
Jul 17 • 03:59PM ET Dollar change+0.65 Percentage change(1.75%)
Aftermarket Close
37.87
Aftermarket • 04:04PM ET Dollar change0.00 Percentage change(0.00%)
Overview Compare Short Interest Financials Options Filings
Healthcare Biotechnology USA Small NASD
Peers: ACAD AXSM KYMR NUVL BMRN RYTM INCY KRYS MDGL NBIX
 | Held by: VTI XBI IWM VXF SCHA IWO TMSL VTWO IWC VHT
Scroll to Statements
Index
RUT
Market Cap
1.61B
Enterprise Value
1.31B
Income
-199.48M
Sales
0.00M
Book/sh
8.84
Cash/sh
7.28
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
133
IPO
Oct 27, 2025
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
4.28
P/C
5.20
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
22.91
Current Ratio
22.91
Debt/Eq
0.01
LT Debt/Eq
0.01
Option/Short
Yes / Yes
EPS (ttm)
-4.52
EPS next Y
-4.13
EPS next Q
-1.32
EPS this Y
72.22%
EPS next Y
19.87%
EPS next 5Y
36.77%
EPS past 3/5Y
-71.59% -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-148.89%
Sales Q/Q
-
Earnings
May 14 AMC
EPS/Sales Surpr.
-27.89% -
Insider Own
82.02%
Insider Trans
-1.70%
Inst Own
30.48%
Inst Trans
3.97%
ROA
-75.23%
ROE
-80.95%
ROIC
-49.31%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
7.72%
SMA50
20.77%
SMA200
67.39%
Trades
Shs Outstand
45.21M
Shs Float
7.66M
Short Float
33.65%
Short Ratio
6.34
Short Interest
2.58M
52W High
40.43 -6.33%
52W Low
12.24 209.40%
Volatility
8.23% 8.18%
ATR (14)
2.73
RSI (14)
61.06
Beta
-
Rel Volume
1.91
Avg Volume
406.60K
Volume
777,245
Perf Week
-3.69%
Perf Month
39.43%
Perf Quarter
32.83%
Perf Half Y
101.87%
Perf YTD
115.60%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
1.00
Target Price
41.50
Prev Close
37.22
Price
37.87
Change
1.75%
Date Action Analyst Rating Change Price Target Change
Jun-25-26Initiated Raymond James Strong Buy $46
May-27-26Initiated UBS Buy $48
May-21-26Initiated Craig Hallum Buy $43
May-04-26Initiated H.C. Wainwright Buy $45
Apr-08-26Initiated Needham Buy $37
Apr-07-26Initiated TD Cowen Buy
Mar-19-26Initiated Canaccord Genuity Buy $35
Nov-21-25Initiated Stifel Buy $28
Nov-21-25Initiated Morgan Stanley Overweight $34
Nov-21-25Initiated Leerink Partners Outperform $30
Show Previous Ratings
Jun-24-26 07:00AM
MapLight Therapeutics Announces Changes to Board of Directors
(GlobeNewswire) +7.02%
Jun-22-26 07:00AM
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
(GlobeNewswire)
May-14-26 04:05PM
MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
(GlobeNewswire)
May-08-26 07:00AM
MapLight Therapeutics to Participate in Upcoming Investor Conferences
(GlobeNewswire) -6.16%
May-01-26 07:00AM
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
(GlobeNewswire)
07:00AM Loading…
Mar-26-26 07:00AM
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
(GlobeNewswire) +6.01%
Mar-02-26 07:00AM
MapLight Therapeutics to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Jan-09-26 07:00AM
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
(GlobeNewswire)
Jan-05-26 07:00AM
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer's Disease Psychosis
(GlobeNewswire)
Dec-16-25 07:00AM
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
(GlobeNewswire)
Dec-04-25 07:00AM
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
(GlobeNewswire) +8.39%
Nov-07-25 07:26PM
MapLight Therapeutics, Gold Royalty, and More Stocks See Action From Activist Investors
(Barrons.com)
Oct-29-25 09:06AM
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
(GlobeNewswire)
Oct-26-25 05:30PM
MapLight Therapeutics Announces Pricing of Initial Public Offering
(GlobeNewswire)
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.
M.D.Dr. Christopher A. Kroeger M.B.A.
Ph.D.Dr. Robert C. Malenka M.D.
Ph.D.Dr. Erin Pennock Foff M.D.
FounderDr. Karoly Nikolich Ph.D.
Ph.D.Dr. Karl Deisseroth M.D.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jonathan GillisOfficerJul 15 '26Proposed Sale37.9136,9791,401,874Jul 15 07:59 PM
Anatol KreitzerOfficerJul 15 '26Proposed Sale37.9133,6051,273,966Jul 15 07:56 PM
Foff Erin PennockOfficerJul 15 '26Proposed Sale37.9148,1581,825,670Jul 15 04:44 PM
ROBERT MALENKADirectorJul 15 '26Proposed Sale37.9117,537664,828Jul 15 04:23 PM
Kroeger Christopher A.OfficerJul 15 '26Proposed Sale37.91152,2305,771,039Jul 15 04:17 PM
Hanson KristopherOfficerJul 15 '26Proposed Sale37.9116,508625,818Jul 15 04:11 PM
Lillie James WoodruffOfficerJul 15 '26Proposed Sale37.9118,835714,035Jul 15 04:01 PM
Kroeger Christopher A.Chief Executive OfficerMay 18 '26Sale27.19118,2353,215,0001,394,094May 18 09:27 PM
Hanson KristopherGeneral CounselMay 11 '26Sale30.1313,917419,263162,331May 11 09:30 PM
Kroeger Christopher A.Chief Executive OfficerMay 08 '26Sale27.6934,411952,8351,526,309May 11 09:30 PM
Kroeger Christopher A.Chief Executive OfficerMay 07 '26Sale28.6520,100575,7971,560,720May 11 09:30 PM
Kroeger Christopher A.Chief Executive OfficerMay 11 '26Sale30.1113,980421,0021,512,329May 11 09:30 PM
Foff Erin PennockChief Medical OfficerMay 07 '26Sale28.544,438126,640346,059May 11 09:30 PM
Lillie James WoodruffChief Scientific OfficerMay 07 '26Sale28.2872120,390242,729May 11 09:30 PM
Setia VishwasChief Financial OfficerMay 04 '26Sale28.1114,904418,930377,723May 06 08:15 PM
Setia VishwasChief Financial OfficerMay 05 '26Sale28.2010,903307,444366,820May 06 08:15 PM
Setia VishwasChief Financial OfficerMay 06 '26Sale28.2410,564298,345356,256May 06 08:15 PM
Foff Erin PennockChief Medical OfficerMay 06 '26Sale28.7624,052691,749350,497May 06 08:15 PM
Foff Erin PennockChief Medical OfficerMay 04 '26Sale27.9615,652437,629385,125May 06 08:15 PM
Foff Erin PennockChief Medical OfficerMay 05 '26Sale28.2010,576298,216374,549May 06 08:15 PM
Lillie James WoodruffChief Scientific OfficerMay 06 '26Sale28.7624,811713,599243,450May 06 08:15 PM
Lillie James WoodruffChief Scientific OfficerMay 04 '26Sale27.9615,801441,813279,356May 06 08:15 PM
Lillie James WoodruffChief Scientific OfficerMay 05 '26Sale28.2011,095312,839268,261May 06 08:15 PM
Hanson KristopherGeneral CounselMay 04 '26Sale27.8913,917388,177176,248May 06 08:15 PM
Kroeger Christopher A.Chief Executive OfficerMay 06 '26Sale28.7623,701681,5831,580,820May 06 08:15 PM
Kroeger Christopher A.Chief Executive OfficerMay 04 '26Sale27.9615,571435,3631,614,993May 06 08:15 PM
Kroeger Christopher A.Chief Executive OfficerMay 05 '26Sale28.2010,472295,2891,604,521May 06 08:15 PM
Kroeger Christopher A.OfficerMay 04 '26Proposed Sale30.70236,4707,259,629May 04 05:47 PM
Setia VishwasOfficerMay 04 '26Proposed Sale30.7036,3711,116,590May 04 05:28 PM
Foff Erin PennockOfficerMay 04 '26Proposed Sale30.7054,7181,679,843May 04 05:22 PM
Lillie James WoodruffOfficerMay 04 '26Proposed Sale30.7052,4281,609,540May 04 05:20 PM
Hanson KristopherOfficerMay 04 '26Proposed Sale30.7027,834854,504May 04 05:18 PM
GILLIS JONATHANCAAO and PAOApr 27 '26Sale29.7451,9001,543,369199,154Apr 29 04:30 PM
GILLIS JONATHANCAAO and PAOApr 28 '26Sale30.3517,935544,319181,219Apr 29 04:30 PM
Kreitzer AnatolChief Discovery OfficerApr 27 '26Sale29.6645,4221,347,066211,190Apr 29 04:30 PM
ANATOL KREITZEROfficerApr 27 '26Proposed Sale29.7645,4221,351,759Apr 27 04:34 PM
JONATHAN GILLISOfficerApr 27 '26Proposed Sale29.7669,8352,078,290Apr 27 04:32 PM
Kreitzer AnatolChief Discovery OfficerApr 15 '26Sale26.613,31688,239256,612Apr 17 04:05 PM
GILLIS JONATHANCAAO and PAOApr 15 '26Sale26.613,59095,530251,054Apr 17 04:05 PM
Hanson KristopherGeneral CounselApr 15 '26Sale26.801,52940,977190,463Apr 17 04:05 PM
Hanson KristopherGeneral CounselApr 16 '26Sale27.372988,157190,165Apr 17 04:05 PM
Setia VishwasChief Financial OfficerApr 15 '26Sale26.872,80675,397392,743Apr 17 04:05 PM
Setia VishwasChief Financial OfficerApr 16 '26Sale27.371163,175392,627Apr 17 04:05 PM
Lillie James WoodruffChief Scientific OfficerApr 16 '26Sale27.372,78376,175295,157Apr 17 04:05 PM
Lillie James WoodruffChief Scientific OfficerApr 15 '26Sale26.821,73046,399297,940Apr 17 04:05 PM
Foff Erin PennockChief Medical OfficerApr 15 '26Sale26.842,04454,861401,946Apr 17 04:05 PM
Foff Erin PennockChief Medical OfficerApr 16 '26Sale27.371,16931,998400,777Apr 17 04:05 PM
Kroeger Christopher A.Chief Executive OfficerApr 16 '26Sale27.3710,052275,1411,630,564Apr 17 04:05 PM
Kroeger Christopher A.Chief Executive OfficerApr 15 '26Sale26.939,135246,0061,640,616Apr 17 04:05 PM
Malenka Robert C.DirectorApr 15 '26Sale26.908,593231,152316,466Apr 17 04:05 PM
Anatol KreitzerOfficerApr 15 '26Proposed Sale27.025,000135,100Apr 15 05:20 PM
Jonathan GillisOfficerApr 15 '26Proposed Sale27.024,000108,080Apr 15 05:15 PM
ROBERT MALENKADirectorApr 15 '26Proposed Sale27.028,593232,183Apr 15 04:47 PM
Kroeger Christopher A.OfficerApr 15 '26Proposed Sale27.0220,822562,610Apr 15 04:28 PM
Setia VishwasOfficerApr 15 '26Proposed Sale27.022,99080,799Apr 15 04:17 PM
Lillie James WoodruffOfficerApr 15 '26Proposed Sale27.024,896132,290Apr 15 04:14 PM
Hanson KristopherOfficerApr 15 '26Proposed Sale27.021,82749,366Apr 15 04:11 PM
Foff Erin PennockOfficerApr 15 '26Proposed Sale27.023,47293,813Apr 15 04:06 PM
Malenka Robert C.DirectorFeb 23 '26Sale18.4211,264207,464325,795Feb 24 06:57 PM
Malenka Robert C.DirectorFeb 20 '26Sale18.032,19539,576337,059Feb 24 06:57 PM
Malenka Robert C.DirectorFeb 24 '26Sale18.1573613,358325,059Feb 24 06:57 PM
ROBERT MALENKADirectorFeb 24 '26Proposed Sale18.1473613,355Feb 24 04:36 PM
ROBERT MALENKADirectorFeb 23 '26Proposed Sale18.4211,264207,491Feb 23 04:33 PM
Pavlov GeorgeDirectorFeb 18 '26Buy17.4810,658186,30210,658Feb 20 06:25 PM
Pavlov GeorgeDirectorFeb 20 '26Buy17.869,920177,17125,000Feb 20 06:25 PM
Pavlov GeorgeDirectorFeb 19 '26Buy17.574,42277,69515,080Feb 20 06:25 PM
ROBERT MALENKADirectorFeb 20 '26Proposed Sale18.032,19539,577Feb 20 04:16 PM
Malenka Robert C.DirectorFeb 13 '26Sale18.2112,116220,632339,254Feb 18 07:33 PM
ROBERT MALENKADirectorFeb 13 '26Proposed Sale18.2112,116220,686Feb 13 04:08 PM
Garnett Timothy JohnDirectorFeb 10 '26Buy17.8914,124252,67814,124Feb 12 05:45 PM
Malenka Robert C.DirectorFeb 10 '26Sale18.126,622119,991351,611Feb 12 05:45 PM
Malenka Robert C.DirectorFeb 11 '26Sale18.002414,338351,370Feb 12 05:45 PM
ROBERT MALENKADirectorFeb 11 '26Proposed Sale18.002414,338Feb 11 04:13 PM
ROBERT MALENKADirectorFeb 10 '26Proposed Sale18.126,622119,963Feb 10 04:22 PM
Malenka Robert C.DirectorFeb 02 '26Sale18.027,039126,843358,234Feb 04 09:15 PM
Malenka Robert C.DirectorFeb 03 '26Sale18.00118358,233Feb 04 09:15 PM
ROBERT MALENKADirectorFeb 03 '26Proposed Sale18.00118Feb 03 04:15 PM
ROBERT MALENKADirectorFeb 02 '26Proposed Sale18.027,039126,835Feb 02 04:37 PM
Malenka Robert C.DirectorJan 29 '26Sale18.5521,262394,410371,885Jan 30 08:50 PM
Malenka Robert C.DirectorJan 28 '26Sale18.656,524121,704393,147Jan 30 08:50 PM
Malenka Robert C.DirectorJan 30 '26Sale18.116,612119,743365,273Jan 30 08:50 PM
ROBERT MALENKADirectorJan 30 '26Proposed Sale18.116,612119,737Jan 30 04:17 PM
ROBERT MALENKADirectorJan 29 '26Proposed Sale18.5521,262394,470Jan 29 04:06 PM
ROBERT MALENKADirectorJan 28 '26Proposed Sale18.656,524121,690Jan 28 04:20 PM
Novo Holdings A/S10% OwnerOct 28 '25Buy17.00952,94116,199,9973,686,622Oct 30 04:31 PM
Catalyst4, Inc.10% OwnerOct 28 '25Buy17.005,441,17692,499,99219,697,464Oct 29 04:16 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)